Phase II trial of sunitinib malate in patients with temozolomide refractory recurrent high-grade glioma

被引：0
|
作者：
Neyns, B. [1 ,2 ]
Chaskis, C. [1 ,2 ]
Dujardin, M. [1 ,2 ]
Everaert, H. [1 ,2 ]
Sadones, J. [1 ,2 ]
Nupponen, N. N. [1 ,2 ]
Michotte, A. [1 ,2 ]
机构：
[1] UZ Brussel, Brussels, Belgium
[2] Univ Helsinki, Helsinki, Finland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2038
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A PHASE II STUDY OF APATINIB PLUS TEMOZOLOMIDE IN ADULTS WITH REFRACTORY RECURRENT HIGH-GRADE GLIOMAS
    Zhang, Jun-ping
    Ge, Jing-jing
    Li, Cheng
    [J]. NEURO-ONCOLOGY, 2018, 20 : 12 - 12
  • [22] Temozolomide as a second-line systemic regimen in recurrent high-grade glioma:: A phase II study
    Brandes, AA
    Ermani, M
    Basso, U
    Amistà, P
    Berti, F
    Scienza, R
    Rotilio, A
    Pinna, G
    Gardiman, M
    Monfardini, S
    [J]. ANNALS OF ONCOLOGY, 2001, 12 (02) : 255 - 257
  • [23] A phase II study of paclitaxel in chemonaive patients with recurrent high-grade glioma
    Postma, TJ
    Heimans, JJ
    Luykx, SA
    van Groeningen, CJ
    Beenen, LFM
    Hoekstra, OS
    Taphoorn, MJB
    Zonnenberg, BA
    Klein, M
    Vermorken, JB
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (04) : 409 - 413
  • [24] A phase II trial of Sunitinib malate in recurrent and refractory ovarian, fallopian tube and peritoneal carcinoma
    Campos, Susana M.
    Penson, Richard T.
    Matulonis, Ursula
    Horowitz, Neil S.
    Whalen, Christin
    Pereira, Lauren
    Tyburski, Karin
    Roche, Maria
    Szymonifka, Jackie
    Berlin, Suzanne
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 128 (02) : 215 - 220
  • [25] Phase II trial of functional imaging-optimized stereotactic fractionated radiotherapy plus temozolomide for recurrent high-grade glioma.
    Nieder, C
    Wiedenmann, N
    Stark, S
    Grosu, AL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 120S - 120S
  • [26] A PHASE II TRIAL OF TAMOXIFEN AND BORTEZOMIB IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
    Aregawi, Dawit
    Kreisl, Teri N.
    Innis, Ellen
    Fine, Howard A.
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [27] A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma
    Jennifer L. Clarke
    Annette M. Molinaro
    Juan R. Cabrera
    Ashley A. DeSilva
    Jane E. Rabbitt
    Joshua Prey
    Daryl C. Drummond
    Jaeyeon Kim
    Charles Noble
    Jonathan B. Fitzgerald
    Susan M. Chang
    Nicholas A. Butowski
    Jennie W. Taylor
    John W. Park
    Michael D. Prados
    [J]. Cancer Chemotherapy and Pharmacology, 2017, 79 : 603 - 610
  • [28] A phase 0 pharmacokinetic trigger trial of infigratinib in patients with recurrent high-grade glioma
    Sanai, Nader
    Margaryan, Tigran
    Molloy, Jennifer
    DeSantis, Anita
    Harmon, Jocelyn
    Hong, Amy
    Braun, Kelly
    Wanebo, John
    Yoo, Wonsuk
    Tien, An-Chi
    Tovmasyan, Artak
    Mehta, Shwetal
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma
    Clarke, Jennifer L.
    Molinaro, Annette M.
    Cabrera, Juan R.
    DeSilva, Ashley A.
    Rabbitt, Jane E.
    Prey, Joshua
    Drummond, Daryl C.
    Kim, Jaeyeon
    Noble, Charles
    Fitzgerald, Jonathan B.
    Chang, Susan M.
    Butowski, Nicholas A.
    Taylor, Jennie W.
    Park, John W.
    Prados, Michael D.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (03) : 603 - 610
  • [30] VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL
    Peters, Katherine
    Reardon, David
    Randazzo, Dina
    Dutton, Shelley
    Edwards, Ashley
    Lipp, Eric
    Herndon, James, II
    McSherry, Frances
    Desjardins, Annick
    Ranjan, Tulika
    Vlahovic, Gordana
    Friedman, Henry
    [J]. NEURO-ONCOLOGY, 2014, 16
12345